Cardiac connexins as candidate genes for idiopathic atrial fibrillation

Current Opinion in Cardiology

Volumn 21, Issue 3, 2006, Pages 155-158

  Gollob, Michael H ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 40; CONNEXIN 43; GAP JUNCTION PROTEIN;

DRUG TARGETING; FUNCTIONAL PROTEOMICS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART CONDUCTION; HEART ELECTROPHYSIOLOGY; HEART VENTRICLE TACHYCARDIA; IDIOPATHIC DISEASE; MOLECULAR GENETICS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; TISSUE DISTRIBUTION;

ANIMALS; ATRIAL FIBRILLATION; CONNEXIN 43; CONNEXINS; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; GAP JUNCTIONS; HUMANS; MICE; MICE, KNOCKOUT;

EID: 33748180168     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hco.0000221574.95383.6f     Document Type: Review

References (33)

1. Feinberg WM, Blackshear JL, Laupacis A, et al. Prevalence, age distribution, and gender of patients with atrial fibrillation: analysis and implications. Arch Intern Med 1995; 155:469-473.
2. Phillips K, Go AS, Hylek EM, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001; 285:2370-2375.
3. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly - The Framingham Study. Arch Intern Med 1987; 147:1561-1564.
4. Benjamin EJ, Wolf PA, D'Agostino RB, et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998; 98:946-952.
5. Wattigney WA, Mensah GA, Croft JB. Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention. Circulation 2003; 108:711-716.
6. Puck JM, Straus SE. Somatic mutations: not just for cancer anymore. N Engl J Med 2004; 351:1388-1390.
7. Spach MS, Starmer CF. Altering the topology of gap junctions: a major therapeutic target for atrial fibrillation. Cardiovasc Res 1995; 30:336-344.
8. Kanno S, Saffitz JE. The role of myocardial gap junctions in electrical conduction and arrhythmogenesis. Cardiovasc Pathol 2001; 10:169-177.
9. Vozzi C, Dupont E, Coppen SR, et al. Chamber-related differences in connexin expression in the human heart. J Mol Cell Cardiol 1999; 31:991-1003.
10. Sohl G, Willecke K. Gap junctions and the connexin protein family. Cardiovasc Res 2004; 62:228-232.
11. Hagendorff A, Schumacher B, Kirchhoff S, et al. Conduction disturbances and increased atrial vulnerability in connexin40-deficient mice analyzed by transesophageal stimulation. Circulation 1999; 99:1508-1515.
12. Stauffer KA. The gap junction proteins beta(1)-connexin (connexin-32) and beta(2)-connexin (connexin-26) can form heteromeric hemichannels. J Biol Chem 1995; 270:6768-6772.
13. Valiunas V, Gemel, Brink PR, et al. Gap junction channels formed by coexpressed connexin40 and connexin43. Am J Physiol Heart Circ Physiol 2001; 281:H1675-H1689.
14. Gu H, Smith FC, Taffet SM, et al. High incidence of cardiac malformations in connexin40-deficient mice. Circ Res 2003; 93:201-206.
15. Reaume AG, de Sousa PA, Kulkarni S, et al. Cardiac malformations in neonatal mice lacking connexin43. Science 1995; 267:1831-1834.
16. Kruger O, Plum A, Kim JS, et al. Defective vascular development in connexin45 deficient mice. Development 2000; 127:4179-4193.
17. Kumai M, Nishii K, Nakamura K, et al. Loss of connexin45 causes a cushion defect in early cardiogenesis. Development 2000; 127:3501-3512.
18. Krutovskikh V, Yamasaki H. Connexin gene mutations in human genetic diseases. Mutat Res 2000; 462:197-207.
19. Britz-Cunningham SH, Shah MM, Zuppan CW, et al. Mutations in connexin43 gap-junction gene in patients with heart malformations and defects of laterality. N Engl J Med; 332:1323-1329.
20. Dasgupta C, Martinez AM, Zuppan CW, et al. Identification of connexin43 (alpha1) gap junction gene mutations in patients with hypoplastic left heart syndrome by denaturing gradient gel electrophoresis (DGGE). Mut Res 2001; 479:273-286.
21. Panzekas WA, Boyadjiev SA, Shapiro RE, et al. Connexin 43 (GJA1) mutations cause the pleiotropic phenotype of oculodentodigital dysplasia. Am J Hum Genet 2003; 72:408-418.
22. Konings KT, Kirchhof CJ, Smeets JR, et al. High-density mapping of electrically induced atrial fibrillation in humans. Circulation 1994; 89:1665-1680.
23. Cox JL, Canavan TE, Schuessler RB, et al. The surgical treatment of atrial fibrillation: II. Intraoperative electrophysiologic mapping and description of the electrophysiologic basis of atrial flutter and fibrillation. J Thorac Cardiovasc Surg 1991; 101:406-426.
24. Spach MS, Josephson ME. Initiating reentry: the role of nonuniform anistropy in small circuits. J Cardiovasc Electrophysiol 1994; 5:182-209.
25. Markides V, Schilling RJ, Ho SY, et al. Characterization of the left atrial activation in the intact human heart. Circulation 2003; 107:733-739.
26. Todd DM, Skanes AC, Guiraudon G, et al. Role of the posterior left atrium and pulmonary veins in human lone atrial fibrillation: electrophysiological and pathological data from patients undergoing atrial fibrillation surgery. Circulation 2003; 108:3108-3114.
27. Gutstein DE, Morely GE, Vaidya D, et al. Heterogeneous expression of gap junction channels in the heart leads to conduction defects and ventricular dysfunction. Circulation 2001; 104:1194-1199.
28. Peters NS, Green CR, Poole-Wilson PA, et al. Reduced content of connexin43 gap junctions in ventricular myocardium from hypertrophied and ischemic human hearts. Circulation 1993; 88:864-875.
29. Kaprielian RR, Gunning M, Dupont E, et al. Downregulation of immunodetectable connexin43 and decreased gap junction size in the pathogenesis of chronic hibernation in the human left ventricle. Circulation 1998; 97:651-660.
30. Dilaveris PE, Gialafos EJ, Sideris SK, et al. Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Hear J 1998; 135:783-788.
31. Kirchoff S, Nelles E, Hagendorff A, et al. Reduced cardiac conduction velocity and predisposition to arrhythmias in connexin40-deficient mice. Curr Biol 1998; 8:299-302.
32. van der Velden HM, van Kempen MJ, Wijffels MC, et al. Altered pattern of connexin40 distribution in persistent atrial fibrillation in the goat. J Cardiovasc Electrophysiol 1998; 9:596-607.
33. Firouzi M, Ramanna H, Kok B, et al. Association of human connexin40 gene polymorphisms with atrial vulnerability as a risk factor for idiopathic atrial fibrillation. Circ Res 2004; 95:e29-e33.